Naura Technology Group
Capital-equipment sales to semiconductor fabs (12-inch/8-inch), with growing recurring revenue from services, spares and upgrades; secondary lines in vacuum, new-energy/photovoltaic and precision electronic components.
Earnings, margins, COGS & capex
Revenue compounded 30-60% for most of the last five years, reaching CNY 39.35B in FY2025 (+30.9%) and ~CNY 41.5B TTM. FY2025 net profit attributable to shareholders actually DECLINED ~1.8% to CNY 5.52B (from CNY 5.62B in FY2024) — EPS fell from CNY 7.83 to CNY 7.65 — as R&D spend surged and product-mix/cost pressures compressed net margin to ~14% even as gross margins improved. Q1 2026 revenue CNY 10.32B (+25.8%) with net profit CNY 1.63B (+3.4%). Consensus/institutional forecasts point to FY2026 revenue CNY 46.79-52.02B and net profit CNY 7.75-10.79B — implying a sharp re-acceleration of profit if delivered.
Income statement — where each revenue dollar goes
% of revenueOf every $1 of revenue, ~60¢ is cost of goods and ~24¢ operating expense, leaving ~16¢ of operating profit (~14¢ net).
Revenue trend
Margins
improving with richer equipment mix
pressured by R&D ramp; not precisely disclosed here
compressed in FY2025 (net profit -~1.8% vs revenue +31%)
COGS structure
Dominated by precision mechanical/vacuum components, RF power and control electronics, and skilled assembly labor; historically some reliance on imported subsystems (RF generators, mass-flow controllers, pumps) being progressively localized; rising input and competition costs squeezed FY2025 unit economics.
Capex
Heavy investment in capacity expansion and multiple new tool platforms; exact FY2025 capex not disclosed here. R&D is the larger swing item — Q1'26 R&D CNY 1.40B (+36.6% YoY) — and is the primary driver of the FY2025 profit decline.
Latest earnings
in line to modestly ahead on revenue; net profit growth muted (+3.4%) on R&D surge
FY2026 consensus/institutional forecast (not formal company guidance): revenue CNY 46.79-52.02B; net profit CNY 7.75-10.79B
- Q1'26 revenue
- CNY 10.32B (+25.8%)
- Q1'26 net profit
- CNY 1.63B (+3.4%)
- Q1'26 R&D
- CNY 1.40B (+36.6%)
- Q1'26 operating cash flow
- CNY 748M (+143%)
Growth drivers
- China fab localization / import-substitution — domestic foundries and memory makers replacing Applied Materials, Lam and Tokyo Electron tools where feasible
- Etch and thin-film deposition (PVD/CVD/ALD) share gains, reportedly including etch/deposition tools used at 7nm-class nodes by a domestic foundry
- Broadening process coverage via M&A (e.g. the Kingsemi track/coating-tool acquisition) toward an end-to-end front-end tool portfolio
- Capacity build-out at SMIC, Hua Hong, CXMT, YMTC and new mature-node fabs driving multi-tool orders per fab ramp
- Growing recurring revenue from spares, services and upgrades on a large installed base
- Adjacent vacuum, new-energy/PV and precision-component lines
Bull & bear
The consolidating national champion of Chinese wafer-fab equipment, riding a multi-year, policy-mandated import-substitution wave with the broadest domestic tool portfolio and share gains at the leading edge.
- Only Chinese firm in the global top-10 WFE vendors, with revenue compounding 30%+ and FY2026 consensus forecasts implying continued 25-30%+ growth
- Localization is structural, not cyclical: every US export-control tightening enlarges NAURA's addressable domestic replacement market
- Reported etch/deposition supply at 7nm-class nodes signals the leading-edge gap is narrowing, not static
- Broadest China process coverage (etch/deposition/clean/furnace) makes it the default multi-tool supplier per fab ramp, seeding a durable service annuity
- FY2026 consensus net profit of CNY 7.75-10.79B (vs CNY 5.52B in 2025) would mark a sharp profit re-acceleration as R&D-heavy platforms mature and mix richens
- Kingsemi acquisition adds track/coating tools, moving NAURA toward a more complete front-end line and cross-sell into the same fab customers
A richly valued, policy-dependent equipment maker whose profit has actually shrunk under R&D and cost pressure, still well behind global leaders and exposed to both export controls and domestic price wars.
- FY2025 net profit fell ~1.8% against +31% revenue — the business is buying growth by sacrificing profit, and a trailing P/E near 113 discounts flawless execution and a profit rebound that hasn't yet shown up
- Demand is concentrated in China fab capex, a subsidy- and policy-driven cycle that can turn sharply lower
- Still trails Applied Materials, Lam, TEL and ASML on leading-edge capability; the hardest nodes remain gated by litho NAURA doesn't make
- Export controls can choke access to imported subsystems and IP that its tools still depend on
- Rising domestic competition (AMEC, Piotech, ACM) plus state pressure to cut fab costs threaten pricing power and margins
- Consensus 12-month price target (~CNY 662) sits well below the ~CNY 860 spot, implying the market prices in more than sell-side models support
What it is worth
Relative multiples + forecast-implied earnings; qualitative given China listing and policy-driven cycle.
FY2025's profit decline persists and/or a China fab-capex down-cycle plus export-control supply shocks hit demand; a ~113x trailing multiple derates sharply toward peer levels.
Revenue compounds ~25-30% with net profit re-accelerating toward the consensus midpoint (~CNY 9B); valuation stays elevated but growth-supported, vulnerable to any China-capex or margin disappointment.
If FY2026 profit reaches the high end (CNY 10.79B, ~+95%) and localization keeps expanding TAM, the premium multiple is partly justified by durable 25-30%+ growth and a genuine margin recovery.
Trades at a large premium to global WFE peers (trailing P/E ~113, forward ~60-67 on consensus vs AMAT/LRCX in the ~20-30x range), reflecting China-champion scarcity and localization optionality rather than current profitability — FY2025 net profit actually fell ~1.8%. Market cap ~$87B on ~$5.8B TTM revenue (~15x sales). Consensus 12-month price target (~CNY 662, range ~515-818) sits ~30% below the ~CNY 860 spot, implying the market prices in more than sell-side models. Not a buy/own recommendation for US investors — China-listed, foreign-access-restricted, and geopolitically exposed; discussed for analytical context only.
SWOT
Strengths
- Largest China wafer-fab-equipment vendor and only Chinese firm in the global top 10 (ranked ~#6 by revenue in 2024)
- Broadest domestic process coverage (etch, PVD/CVD/ALD, cleaning, furnace/oxidation-diffusion-anneal)
- Structural tailwind from state-backed chip self-sufficiency and export-control pressure on US/JP incumbents
- Deep, sticky relationships with essentially every major Chinese fab; large installed base seeding recurring revenue
- Strong balance sheet and self-funded, escalating R&D
Weaknesses
- Net margin thin and outright declining in FY2025 — net profit fell ~1.8% while revenue rose 31%, as heavy R&D and cost inflation overwhelmed profit conversion
- Trails Applied Materials, Lam, TEL and ASML on leading-edge capability, throughput, yield and breadth
- Revenue heavily concentrated in mainland China / a policy-driven demand cycle
- Still dependent on some imported subsystems and, indirectly, on tools it cannot yet replace (e.g. EUV litho — not a NAURA product)
- Extreme valuation (trailing P/E ~113) leaves little room for execution slips
Opportunities
- Deepen sub-14nm/7nm-class etch and deposition penetration as domestic advanced-node capacity expands
- Displace remaining foreign tools in mature-node and memory fabs (CXMT, YMTC ramps)
- Widen recurring service/upgrade annuity on a growing installed base
- Portfolio expansion via M&A — e.g. the Kingsemi (track/coating) acquisition — into metrology, packaging and litho-adjacent tools
- Export to non-US-aligned markets over time
Threats
- Tighter US/allied export controls could cut access to critical sub-components and IP
- Domestic overcapacity / subsidy-driven price competition from AMEC, Piotech, ACM and others compressing margins
- A China fab-capex down-cycle would hit lumpy equipment demand hard
- Leading-edge gap persists if advanced litho remains unavailable to Chinese fabs
- Multiple compression if profit growth keeps lagging revenue
Moats, dependencies & bottlenecks
Moats
High while US-China tech decoupling persists State-backed self-sufficiency mandate makes NAURA the default domestic choice; a geopolitical, not purely technical, moat.
Qualified process recipes and fab-integrated tools are costly and slow to swap; seeds recurring spares/service revenue.
Moderate-Strong Only domestic vendor spanning etch, deposition, cleaning and furnace — one-stop supplier advantage per fab ramp.
Largest China WFE R&D budget on a large workforce, but still sub-scale vs AMAT/LRCX global R&D.
Dependencies
Revenue is lumpy and concentrated in a policy-driven domestic capex cycle.
Demand and localization mandate are state-shaped; a policy shift or budget pullback bites directly.
Progressively localized but still partly dependent on foreign components exposed to export controls.
Not a NAURA product; leading-edge fab demand is gated by litho tools (ASML EUV) Chinese fabs cannot freely buy.
Advantages
- Scale and portfolio breadth unmatched among Chinese WFE peers
- Privileged access to virtually all domestic fabs
- Direct beneficiary of every escalation in US-China chip-tool decoupling
- Self-funded, rapidly rising R&D on a strong balance sheet
Weaknesses
- Net profit declined in FY2025 despite strong top-line growth
- Extreme valuation leaves no room for execution error
- China-concentrated, policy-dependent revenue base
- Technology gap at the leading edge remains real
Bottlenecks
- Leading-edge process capability gap vs global incumbents (throughput, yield, sub-7nm)
- Access to critical imported sub-components under export controls
- Skilled process-engineering talent to scale multiple advanced platforms
- Profit conversion — R&D and cost inflation outrunning revenue growth (net profit fell YoY in FY2025)
Top signals & trends
Top signals
Wide range, but midpoint (~CNY 9.3B, ~+68%) implies profit re-accelerating well above revenue — this is forecast, not delivered.
Confirms ongoing margin drag from heavy reinvestment; FY2025 net profit actually fell.
Evidence the leading-edge gap is narrowing, though specific delivery details are not independently confirmed here.
bullish (for NAURA demand) · Expands the domestic tool-replacement TAM; also a supply-chain threat — double-edged.
Spot sits ~30% above the average sell-side target, implying the market prices in more than sell-side models support.
Consolidates a domestic peer into NAURA's portfolio, broadening front-end coverage rather than facing it as a rival.
Trends
positive (demand), negative (supply) · The dominant force shaping NAURA's addressable market and component risk simultaneously.
Multi-year replacement of foreign tools across etch, deposition, cleaning, furnace.
Broad capacity expansion lifts equipment demand, though NAURA is China-weighted.
Subsidy-fueled entrants pressure pricing and margins in mature segments.
Caps how far Chinese fabs (and thus NAURA's leading-edge demand) can advance.
NAURA's Kingsemi acquisition typifies a consolidating national-champion structure that concentrates scale and process breadth.
Ecosystem & competitor graph
Suppliers feed the company; customers pull from it. Line thickness shows the strength of each tie (supply-chain dependency, customer earnings contribution). Hover to isolate a tie.
RF power, vacuum, gas-delivery subsystems used in WFE — the class of imported components NAURA is localizing.
RF/plasma power delivery subsystems for etch/deposition tools.
Growing localized base of vacuum pumps, MFCs, chambers and precision parts reducing import reliance (named single-source vendors not disclosed here).
China's largest foundry and NAURA's anchor customer; context only, not a buy/own call.
Mature-node foundry, major NAURA equipment buyer; context only.
Leading Chinese DRAM (CXMT) and NAND (YMTC) makers ramping capacity; privately/state-held, key demand drivers.
Global #1 WFE vendor; leader in deposition, etch, CVD/PVD, metrology — the incumbent NAURA aims to displace in China.
Etch and deposition leader; directly overlaps NAURA's core etch/thin-film franchise.
Coat/develop, etch, deposition, cleaning leader; broad overlap with NAURA's portfolio.
Lithography monopoly (EUV/DUV); not a direct product overlap but the key gating tool for the advanced nodes NAURA's customers want.
Process control/metrology/inspection leader — an adjacent segment NAURA has limited presence in.
Chinese etch specialist and closest domestic rival in plasma etch; context only, not a buy/own call.
US-listed, China-focused wafer-cleaning specialist; competes in NAURA's cleaning segment.
Chinese thin-film deposition (CVD/ALD) vendor competing with NAURA's deposition line; context only.